Yunli Yu

Summary

Publications

  1. ncbi Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies
    Yunli Yu
    Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, PR China
    Biochem Pharmacol 79:1000-6. 2010
  2. ncbi Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?
    Sen Yu
    Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, P R China
    Planta Med 76:876-81. 2010

Collaborators

  • Guangji Wang
  • Sen Yu
  • Xinting Wang
  • Li Liu
  • Xiaodong Liu
  • Lin Xie
  • Yan Liang
  • Shousi Lu

Detail Information

Publications2

  1. ncbi Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies
    Yunli Yu
    Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, PR China
    Biochem Pharmacol 79:1000-6. 2010
    ..Some signal pathways including PKC-dependent pathway were involved in this process. Elucidation of mechanisms controlling berberine-mediated GLP-1 secretion may facilitate the understanding of berberine's antidiabetic effects...
  2. ncbi Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?
    Sen Yu
    Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, P R China
    Planta Med 76:876-81. 2010
    ..All these results suggested that the function and expression of P-GP were impaired in the intestine of STZ-induced diabetic rats which, at least partly, contributed to the exposure increase of the five protoberberine alkaloids...